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Mechanisms for Activation and Antagonism
of an AMPA-Sensitive Glutamate Receptor: Crystal
Structures of the GluR2 Ligand Binding Core
mann, 1994; Nakanishi and Masu, 1994; Dingledine et al.,
1999). Receptors that are most sensitive to the synthetic
agonist a-amino-3-hydroxy-5-methyl-4-isoxazole pro-
pionic acid (AMPA) are so-called AMPA receptors
(GluR1-4; Borges and Dingledine, 1998); receptors
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activated by the naturally occurring neurotoxin and ago-New York, New York 10032
nist kainate have been deemed kainate receptors
(GluR5-7, KA1-2; Lerma et al., 1997; Chittajallu et al.,
1999); and receptors that require both glycine and gluta-
mate for activation, but are also activated by syntheticSummary
N-methyl-D-aspartate, have been named NMDA recep-
tors (NMDAR1, NMDAR2a–d; Yamakura and Shimoji,Crystal structures of the GluR2 ligand binding core
1999). Although the “orphan” d1 and d2 receptors (Lo-(S1S2) have been determined in the apo state and in
meli et al., 1993) neither bind glutamate nor form homo-the presence of the antagonist DNQX, the partial agonist
meric channels, they are nevertheless implicated in mo-kainate, and the full agonists AMPA and glutamate.
tor coordination (Kashiwabuchi et al., 1995), andThe domains of the S1S2 ligand binding core are ex-
mutations in these receptors can dramatically perturbpanded in the apo state and contract upon ligand bind-
central nervous system function (Zuo et al., 1997). Not-ing with the extent of domain separation decreasing
withstanding variations in sequence and function, thein the order of apo . DNQX . kainate . glutamate >
overarching similarities between AMPA, kainate, andAMPA. These results suggest that agonist-induced
NMDA receptors suggest that our studies of the mecha-domain closure gates the transmembrane channel and
nisms for agonist and antagonist action at AMPA recep-the extent of receptor activation depends upon the
tors may be directly applicable to kainate and NMDAdegree of domain closure. AMPA and glutamate also
receptors and may be generally useful in the under-promote a 1808 flip of a trans peptide bond in the ligand
standing of other classes of ligand-gated ion channels.binding site. The crystal packing of the ligand binding
AMPA receptor agonists elicit a range of peak, steady-cores suggests modes for subunit–subunit contact in
state, and single-channel currents and have widely vary-the intact receptor and mechanisms by which alloste-
ing equilibrium dissociation constants. On the one hand,ric effectors modulate receptor activity.
AMPA and glutamate evoke similar electrophysiological
responses even though AMPA binds z20-fold moreIntroduction
tightly than glutamate, depending on the receptor sub-
type (Andersen et al., 1996; Bra¨uner-Osborne et al.,The transduction of external signals across the cellular
2000). In whole-cell recordings saturating concentra-membrane and into the cytoplasm is a process funda-
tions of AMPA and glutamate give rise to similar re-mental to the evolution, development, and function of all
sponses: they both produce large inward currents thatliving organisms. In the case of the mammalian nervous
rapidly desensitize to 1%–10% of the peak amplitudesystem, fast synaptic transmission between nerve cells
within tens of milliseconds, depending on the specificis primarily carried out by ionotropic glutamate recep-
receptor (Kiskin et al., 1986; Trussell et al., 1988; Mos-tors (iGluRs), a class of transmembrane proteins that
bacher et al., 1994; Partin et al., 1994; Koike et al., 2000).form glutamate-gated ion channels. In response to glu-
Single-channel studies also indicate that the amplitude
tamate released by a presynaptic cell, the transmem-
of the conductance states elicited by AMPA and gluta-
brane gate of iGluRs briefly opens, depolarizing the
mate at recombinant AMPA receptors are similar (Swan-
postsynaptic cell and generating a receptor potential. son et al., 1997b). On the other hand, peak currents
A receptor potential of sufficient strength will trigger an evoked by kainate acting at AMPA receptors are much
action potential that will in turn propagate the initial smaller and rapidly desensitize to 70% of the peak am-
stimulus. Even though iGluRs and other families of ligand- plitude (Patneau et al., 1993; Stern-Bach et al., 1998).
gated ion channels such as cyclic nucleotide-gated chan- Single-channel records from homomeric GluR4(i) recep-
nels (Zagotta and Siegelbaum, 1996), nicotinic acetylcho- tors and heteromeric GluR2(i)/GluR4(i) receptors show
line, g-aminobutyric acid and glycine receptors (Unwin, that currents elicited by kainate are 4- to 8-fold smaller
1998), and P2X receptors (North and Barnard, 1997) are than those induced by glutamate or AMPA (Swanson et
fundamental components of many eukaryotic organ- al., 1997b, but see also Smith et al., 2000). Thus, kainate
isms, there is little understanding of the structural basis is a partial agonist that produces rapid and limited de-
for agonist and antagonist action at these receptors. sensitization at AMPA receptors (Kiskin et al., 1986; Pat-
iGluRs define a family of receptors for which there are neau et al., 1993; Stern-Bach et al., 1998). At present
three primary subgroups distinguished by amino acid there is no understanding, at the level of three-dimen-
sequence, pharmacological profile, functional behavior, sional structure, of what distinguishes a partial agonist
and biological role (Seeburg, 1993; Hollmann and Heine- from a full agonist and a weakly bound agonist from a
strongly bound agonist.
iGluRs are modular proteins composed of distinct li-* To whom correspondence should be addressed (e-mail: jeg52@
columbia.edu). gand binding and channel-forming domains (Paas, 1998;
Neuron
166
Figure 1. Ligand Binding Constants for S1S2J
(A) Domain structure of iGluRs showing the S1 and S2 segments in turquoise and pink, respectively. “Cut” and “link” denote the edges of
the S1S2 construct.
(B) KD for 3H-AMPA binding was 24.8 6 1.8 nM.
(C) IC50 for displacement of 3H-AMPA by glutamate, kainate, and DNQX were 821 nM, 14.5 mM, and 998 nM, respectively.
Wo and Oswald, 1995). The agonist and antagonist bind- in the presence of glutamate, AMPA, kainate, and the
antagonist 6,7-dinitro-2,3-quinoxalinedione (DNQX).ing site is localized to a clam shell–like ligand binding
core (Kuusinen et al., 1995; Armstrong et al., 1998) that
is connected to the three transmembrane segments (M1, Results
M2, and M3) and reentrant loop (P) that form the ion
channel. Eukaryotic iGluRs have an amino-terminal do- Construct Design and Structure Determination
To facilitate our crystallographic studies, we designedmain (ATD) that has low-level sequence identity to the
bacterial leucine/isoleucine/valine binding protein (O’Hara a novel construct of the GluR2 flop (Boulter et al., 1990;
Sommer et al., 1990) ligand binding core (S1S2J) thatet al., 1993). The ATD is not involved in ligand binding
(Stern-Bach et al., 1994) but is important for subtype- contained a trypsin site 4 amino acids upstream of the
first ordered residue in the S1S2I-kainate structure (Arm-specific assembly (Leuschner and Hoch, 1999) and me-
diates intersubunit interactions (Kuusinen et al., 1999). strong et al., 1998; Chen et al., 1998), a deletion of the
last amino acid in S1 (Pro-507), and replacement of theBetween the end of the ATD and M1 is one half of the
ligand binding core (S1), and located between M2 and 5 residue linker with the dipeptide Gly-Thr. Trypsinolysis
of S1S2J yielded a 29.2 kDa fragment with the sequenceM3 is the second half (S2). The S1S2 region, which has
weak sequence homology to the bacterial periplasmic GAN392KT···, where the GluR2 sequence begins with Asn-
392 and ends at Ser-775 (numbered according to theglutamine binding protein (QBP) (Nakanishi et al., 1990),
contains the structural elements required to generate predicted mature GluR2 sequence; Keina¨nen et al.,
1990). The KD for 3H-AMPA binding to S1S2J and thethe wild-type responses to agonists and antagonists
(Stern-Bach et al., 1994). In the cases of AMPA, kainate, IC50 values for its displacement by glutamate, kainate,
and DNQX indicate that S1S2J has ligand binding prop-and NMDA receptors, fusing S1 and S2 with a hydro-
philic linker generates a water-soluble construct that erties similar to those determined for longer GluR2 S1S2
constructs (Chen and Gouaux, 1997) and for the full-retains wild-type ligand binding affinities (Kuusinen et
al., 1995; Ivanovic et al., 1998; Keina¨nen et al., 1998). length receptor (Keina¨nen et al., 1990; Andersen et al.,
1996; Hennegriff et al., 1997), as illustrated in Figure 1.Development of large-scale refolding procedures for
GluR2 S1S2 constructs produced as inclusion bodies Crystals of the S1S2J variant in complexes with a series
of ligands diffract to high resolution, as summarized inin Escherchia coli (Chen and Gouaux, 1997) paved the
way for the high-resolution crystallographic studies re- Table 1.
The S1S2I-kainate structure (Armstrong et al., 1998)ported here.
The structure of GluR2 S1S2 complexed with kainate was the search probe in the molecular replacement (MR)
solutions of the S1S2J-glutamate and -kainate struc-identified residues involved in kainate binding; located
sites that modulate agonist specificity and affinity, as tures. Although a promising molecular replacement so-
lution for the DNQX complex was obtained using thewell as receptor desensitization; and mapped potential
subunit–subunit contact sites (Armstrong et al., 1998). S1S2I-kainate structure, the resulting model could not
be refined below a Rfree of 0.40. Therefore, the S1S2J-Nevertheless, the GluR2 S1S2-kainate structure left sev-
eral important questions unanswered. How does the DNQX structure was solved by multiwavelength anoma-
lous diffraction phasing (MAD; Hendrickson, 1991), usingagonist-bound state differ from the apo or antagonist-
bound state? Do full agonists produce greater domain phases from the MR solution to determine the selenium
positions of a selenomethionine derivative (Hendricksonclosure than partial agonists? Do all structurally related
agonists have identical modes of binding? How might et al., 1990). The S1S2J-DNQX structure, in turn, enabled
the solution of the apo crystal form by MR. The electronagonist binding be linked to gating of the ionic channel?
With these questions in mind, we developed a novel density is continuous from Lys-393 to Cys-773 for all
of the structures, and the density for the ligands andprotein construct that enabled us to determine high res-
olution structures of GluR2 S1S2 in the apo state and contacting residues is well resolved. Crystallographic
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refinement statistics for all of the complexes are shown
in Table 2.
DNQX and Apo States Contain an Expanded
Binding Cleft
The domains of the ligand binding core have separated
in the DNQX and apo structures relative to the S1S2I-
kainate structure (Armstrong et al., 1998), revealing an
expanded binding cleft. The four protein molecules in
the apo and DNQX asymmetric units all have moderately
different conformations (ApoA, ApoB, DNQXA, DNQXB;
Figure 2A), as defined by the degree of domain closure,
or separation of domains 1 and 2; superposition of indi-
vidual domains yields low root-mean-square deviation
(rmsd) values (0.22 A˚) indicating that the basis of the
conformational variability is in the orientation of the do-
mains. On average, the DNQX-bound structures are
z2.58 more closed than the apo structures with the maxi-
mal change in domain closure (6.08) occurring between
ApoA and DNQXB. All subsequent structural compari-
sons were performed using the ApoA protomer (most
“open” conformation) as the reference structure.
DNQX binds near the “top” of the cleft, stacks directly
under Tyr-450, and forms hydrogen bonds with 4 resi-
dues in domain 1 and 1 residue in domain 2 (Figure 2C).
The two carbonyl groups mimic the a-carboxyl group
common to agonists, forming hydrogen bonds to Arg-
485 and the hydroxyl and backbone amide of Thr-480.
A DNQX amide nitrogen makes a hydrogen bond to the
backbone carbonyl of Pro-478. The quinoxalinedione
ring lays z3.6 A˚ directly below and parallel to the aro-
matic ring of Tyr-450, thus maximizing p–stacking inter-
actions. Glu-705 adopts an extended conformation in
DNQXB with the g-carboxyl group directly under the
quinoxalinedione rings, while in DNQXA the g-carboxyl
of Glu-705 is bent slightly away from DNQX. The 6-nitro
group interacts with Tyr-732 and a protein-bound water
molecule, and the 7-nitro moiety is within hydrogen
binding distance (2.95 A˚) of the hydroxyl of Thr-686.
There is strong omit map density (5s) in the binding
cleft at the base of helix F in both molecules in the
asymmetric unit of the DNQX crystal form. A sulfate
was modeled into this density in DNQXB based on its
tetrahedral shape and intensity (Figure 2B). The sulfate
interacts with helix F via 3 hydrogen bonds to the protein
and 3 hydrogen bonds to solvent molecules, mimicking
the interactions that the anionic “R” groups of agonists
make with the base of helix F. Located between DNQX
and the bound sulfate is a water molecule. The density
in the binding site of the DNQXA polypeptide chain,
although relatively strong, is elongated in shape, does
not resemble a single sulfate ion, and has not been
modeled. The DNQX and apo crystallization conditions
contained z0.25–0.4 M ammonium sulfate, but there is
no evidence for a bound sulfate at the base of helix F
in apo electron density maps.
In comparing the apo and the DNQX-bound struc-
tures, the major difference in the binding pocket resi-
dues involves Glu-705, which is the counter ion for the
a-amino group of kainate (Armstrong et al., 1998). In the
apo state, Glu-705 forms a salt bridge with Lys-730 and
a hydrogen bond with Thr-655 (helix F). However, in the
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DNQXB structure, the carboxyl group of Glu-705 has
rotated by z1358 about its Cb-Cg bond such that the
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carboxyl group is brought to the center of the binding
cleft and away from Lys-730 and Thr-655 (Figure 2A).
The orientation of Glu-705 in DNQXA is intermediate
between the conformation of Glu-705 in the apo state
and in DNQXB.
Modes of Agonist Binding: Glutamate, AMPA,
and Kainate Structures
Glutamate, AMPA, and kainate, like most glutamate re-
ceptor agonists, are amino acids; the a-carboxyl and
a-amino groups directly interact with the ligand binding
core through 7 ion pair and hydrogen bonding interac-
tions to domains 1 and 2 (Figure 3). While Arg-485 in
domain 1 is the primary anchor for the a-carboxyl group,
the backbone NH groups of Thr-480 (domain 1) and Ser-
654 (domain 2) provide additional hydrogen bonds. Arg-
485 is conserved in all glutamate receptors, and when
mutated to a lysine in GluR1 (Kawamoto et al., 1997) or
in GluR4-S1S2 (Lampinen et al., 1998), AMPA binding
is abolished. The equivalent mutation in NR2B also de-
stroys agonist-evoked currents in the NMDA receptor
complex (Laube et al., 1997).
The a-amino group is secured to domains 1 and 2 by
way of a nearly tetrahedral arrangement of interactions
from the backbone carbonyl oxygen of Pro-478, the
hydroxyl of Thr-480, and a carboxylate oxygen of Glu-
705. Evidence for the importance of the ion pair interac-
tion between the a-amino group and Glu-705 comes
from an experiment which showed that 3H-AMPA bind-
ing cannot be detected when this residue is mutated
to glutamine in GluR4 S1S2 (Lampinen et al., 1998).
Superpositions of the glutamate, AMPA, and kainate
structures show that the fundamental interactions be-
tween the a-carboxyl and -amino groups and Arg-485,
Glu-705, Thr-480, Ser-654, and Pro-478 are conserved
between these three agonists (Figures 3B and 3C).
By contrast to the equivalent and well-defined recep-
tor binding sites for the a-substituents of the agonists,
the binding sites for the anionic moiety attached to the
g carbons of glutamate, kainate, and AMPA are surpris-
ingly distinct. This distinction is not only because there
are a number of solvent-mediated interactions but also
because the positions of interacting waters and side
chains vary in the complexes. In essence, the “g” group
binding pocket is composed of four subsites (D, E, F,
and G in Figure 3D). Subsites D and E are located at
the base of helix F and are formed by the backbone NH
groups of Ser-654 and Thr-655, the hydroxyl of Thr-655,
a water molecule bound to the base of helix F (water
#3), and a water molecule (#2) tethered to the NH group
of Leu-650 and the carbonyl oxygen of Leu-703. The
g-carboxyl groups of glutamate and kainate interact with
the hydrogen bond donors in subsites D and E nearly
identically (Figure 3B). The main difference between the
glutamate and kainate binding clefts is the position of
Leu-650, which moves substantially further into the cleft
(3.0 A˚) in the glutamate-bound state. Interestingly, the
superposition in Figure 3B shows that the kainate iso-
propenyl group, which protrudes from the binding pocket,
would sterically clash with Leu-650 in the glutamate-
bound conformation.
Superposition of the AMPA and glutamate structures
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shows that the “g” substituents are bound to the sub-
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Figure 2. Superposition of the Expanded
Cleft Structures and Stereo View of the DNQX
Binding Site
(A) The two apo molecules (ApoA and ApoB)
and two DNQX molecules (DNQXA and
DNQXB) in each asymmetric unit were super-
imposed using only Ca atoms from domain
1. Apo protomers are shaded red and pink
while DNQX protomers are colored light
green and dark green. DNQX is depicted in
black, and selected side chains from DNQXB
are shown in dark green. The conformational
change undergone by Glu-705 is illustrated
by comparing its orientation in ApoB and
DNQXB. In the apo state, Glu-705 accepts
hydrogen bonds from the side chains of Lys-
730 and Thr-655.
(B) The chemical structure of DNQX and Fo-
Fc omit electron density for DNQX and sulfate
contoured at 2.5 s.
(C) Stereo image of the interactions between
DNQX, sulfate, and S1S2J. DNQXB side chains
are colored gray. Water molecules are shown
as green balls. DNQX is colored black. Hydro-
gen bonds between DNQX, sulfate, and
S1S2J are indicated by black dashed lines.
sites in different orientations (Figure 3C), in contrast to a hydrogen bond to the backbone NH of Glu-705. The
5-methyl group of AMPA binds in subsite G, partiallya prediction that the AMPA isoxazole moiety is bioisost-
eric to the glutamate g-carboxyl group (Honore´ and filling a hydrophobic pocket in domain 1 created by the
reorientation of Met-708 and the side chain atoms ofLauridsen, 1980). Rather than occupying subsites D and
E like the g-carboxyl of kainate and glutamate, the isoxa- Pro-478 and Tyr-405. Met-708, which is in an extended
conformation in the kainate and glutamate structures,zole ring of AMPA binds in subsites E, F, and G. In
the AMPA complex, subsite D is occupied by a water undergoes a rotamer change in order to accommodate
AMPA binding (Figure 3C).molecule (#4) that forms a close interaction with the
isoxazole hydroxyl (2.45 A˚), an a-carboxyl oxygen, and
residues at the base of helix F. The recruitment of water Full Agonists Induce More Domain Closure Than
Partial Agonists#4 by AMPA thus transforms AMPA into a faithful bioi-
sosteric mimic of glutamate. By also occupying subsite The domains of the ligand binding core close upon ago-
nist binding, sequestering the agonist in the cleft. Rela-F, the isoxazole nitrogen displaces water #1 and makes
Neuron
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Figure 3. Modes of Agonist Binding
(A) Fo-Fc omit electron density and chemical
structures for glutamate, AMPA and kainate
in addition to selected water molecules.
Maps are contoured at 3.0 s.
(B) Stereo view of the binding cleft in superim-
posed glutamate and kainate structures. The
glutamate backbone is colored pink, and the
side chains and ligand are colored gray. The
kainate backbone is shown in orange, while
the side chains and ligand are black. The su-
perposition was calculated using Ca atoms
from domain 1. Only hydrogen bonds be-
tween glutamate and S1S2J are shown in (B)
and (C). Selected water molecules in the glu-
tamate and kainate structures are drawn in
pink and green, respectively. Tyr-450 is omit-
ted from (B) and (C) for clarity; the side chain
is positioned directly over the binding site in
this orientation (see [D]).
(C) Stereo view of the binding cleft in superim-
posed glutamate and AMPA structures. The
glutamate structure is colored as in (B). The
AMPA backbone is drawn in blue, and the side
chain and ligand are colored black. The su-
perposition was performed using all Ca
atoms. Waters within hydrogen bonding dis-
tance of AMPA are shown as green balls.
(D) Schematic of the agonist binding site. For
simplicity, all residues except Tyr-450 and
Glu-705 have been flattened onto the plane
of the page using the program LIGPLOT (Wal-
lace et al., 1995). To represent the 3D nature
of the binding cleft, Tyr-450 and Glu-705 are
shown over and under the agonist subsites,
respectively. Subsites drawn in red (A, D, E,
and F) are occupied by hydrogen bond ac-
ceptors, while subsite B (blue) is occupied by
a hydrogen bond donor.
tive to the ApoA conformation, AMPA and glutamate the first strand and Leu-727 and Gly-731 in the second
strand for both the apo to kainate and apo to AMPA/induce z208 of domain closure while kainate induces
only z128 (Figure 4). In other words, the full agonists glutamate transitions. Smaller backbone torsion angle
changes also occur at the C-terminal end of helix I be-AMPA and glutamate bring domains 1 and 2 z88 closer
together than the partial agonist kainate. Unlike the tween Arg-715 and Asp-719. As the location of the rota-
tion axis suggests, helix I from domain 2 reorients withmoderate differences in domain closure observed in the
apo and DNQX structures, the orientations of domains domain 1, while the remainder of domain 2 moves as a
separate rigid body, perhaps because helix I is linked1 and 2 in the six independent AMPA and glutamate
complexes are similar. The two independent kainate via a disulfide bond to domain 1. In the apo to kainate
transition, the rotation axis runs between the two lobesstructures are identical within experimental error and
thus have a similar degree of domain closure. The sub- and intersects the end of helix I, whereas in the apo to
AMPA/glutamate transition, the rotation axis runs ap-stantial conformational change that occurs upon gluta-
mate binding reduces the calculated radius of gyration proximately down the center of helix I.
by 0.8 A˚ relative to the apo state.
In general terms, the rotation describing the domain The Peptide Bond between Asp-651 and Ser-652
Adopts Multiple Conformationsclosure motion occurs about an axis that runs through
the two interdomain b strands and along helix I, as illus- Concomitant with the z208 of domain closure induced
by AMPA is a rearrangement of the protein backbonetrated in Figure 4. Significant changes (208) in backbone
torsion angles occur between Ser-497 and Ile-500 in between Asp-651 and Gly-653 (Figure 5). In particular,
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Figure 4. Relative Domain Closure and Cor-
responding Axes of Rotation for Important
Structural Transitions
All of the superpositions were calculated us-
ing only Ca atoms from domain 1. The S1S2J
backbones are colored according to the
schematics at the bottom of the figure. The
values listed below the superpositions are the
relative extents of domain closure, in de-
grees.
(A) Superposition of apo and kainate (KA)
structures.
(B) Superposition of apo and AMPA struc-
tures.
(C) Superposition of kainate and AMPA struc-
tures.
(D) Plot of the mean domain closure for the
five complexes. All domain closure values
were determined using ApoA as the reference
(08). The three molecules in the AMPA and
glutamate a.u. and the two molecules in the
DNQX and apo a.u. were used to determine
the mean domain closure. For the kainate
complex, the mean was calculated for the
S1S2I and S1S2J structures. The error bars
indicate the minimum and maximum domain
closure values.
the trans peptide bond connecting Asp-651 and Ser- A 2-Fold Symmetric Dimer Is Formed by Crystal
Packing Interactions652 undergoes a z1808 flip relative to its orientation in
the kainate, DNQX, and apo structures. Using the ApoA In all five of the crystal forms obtained using the S1S2J
construct, the protein molecules pack in such a mannerand the AMPA(A) protomers as a representative exam-
ple, we find that the peptide bond flip occurs via a 1808 as to produce a 2-fold symmetric “dimer.” As shown in
Figure 6A, the two protomers are oriented with both Nchange in c at Asp-651 and a 1578 rotation in ` at Ser-
652. In addition, c changes by 808 at Ser-652 and ` termini along the upper face of the dimer, both linker
regions are on the bottom face, and both binding siteschanges by 648 at Gly-653. Although neither Asp-651,
Ser-652, nor Gly-653 directly interacts with ligands, are facing outward. Domain 1 from each of the 2-fold
related protomers comprises the dimer interface, whichthese residues are flanked by Leu-650 and Ser-654,
which form hydrophobic and hydrogen bonding interac- has both hydrophobic and polar interactions and is
made up of helices D and J and the first interdomain btions with agonists. The peptide bond rearrangement
results in two additional hydrogen bonds between do- strand. The interface is similar between all five struc-
tures; for example, superposition of the apo and themains 1 and 2 in the AMPA-bound state; the backbone
carbonyl of Ser-652 hydrogen bonds to the backbone AMPA noncrystallographic symmetry (NCS)-dimers us-
ing a-carbons from domain 1 of each protomer yieldsamide of Gly-451, and a water-mediated hydrogen bond
connects the backbone carbonyl of Asp-651 to the an rmsd of 0.68 A˚.
The “dimer” interface buries 1150 A˚2 of solvent-acces-backbone amide of Tyr-450. All three molecules in the
asymmetric unit of the AMPA crystal form clearly contain sible surface area per protomer and contains 2 salt brid-
ges and 8 hydrogen bonds. Leu-483, which blocks de-the flipped peptide orientation. Glutamate also is capa-
ble of inducing the peptide bond flip, albeit less effec- sensitization when mutated to Tyr in GluR3 (Stern-Bach
et al., 1998), forms a hydrophobic cluster with the con-tively than AMPA. In the glutamate cocrystals, protomer
A is in the unflipped conformation and protomer C is in served residues Leu-748 and Leu-751 on helix J of the
adjacent protomer (Figure 6C); Leu-483 also makes athe flipped conformation. The electron density for this
region in protomer B is not well defined, probably be- number of van der Waals contacts , 3.8 A˚ with Lys-
752, which is located on helix J of the 2-fold relatedcause multiple conformations are occupied.
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Figure 5. The Peptide Bond Flip in the AMPA
Structure
(A) The superposition of the kainate and
AMPA structures is exactly as in Figure 4C.
The stereo diagram illustrates residues in-
volved in peptide bond flipping. Side chains
from the kainate and AMPA structures are
drawn in gray and black, respectively. The
side chains for Asp-651 and Ser-652 have
been omitted for clarity. A water molecule in
the AMPA structure that mediates a hydrogen
bond between the carbonyl of Asp-651 and
the amide of Tyr-450 is drawn as a green ball.
(B) Positive (green) and negative (pink) den-
sity from an Fo-Fc electron density calculated
using Fc coefficients from an “unflipped”
AMPA model. The yellow arrows illustrate the
movement of the Asp-651 carbonyl and side
chain carboxylate to their appropriate posi-
tions. The “unflipped” model is drawn with
the electron density as opposed to the flipped
orientation depicted in (A).
molecule. A symmetric pair of salt links are formed dinate one zinc; His-412 (A) and Asp-454 (C*) bind a
second zinc; the third and fourth interpromoter sites arebetween Glu-486, which is located in helix D of one
protomer, and Lys-493, which is situated in the first formed by His-435 (A), Glu-431 (A), and Glu-678 (B) and
His-435 (B*), Glu-431 (B*), and Glu-678 (A).interdomain b strand on the other protomer; Glu-486
and Lys-493 are conserved across all non-NMDA
iGluRs. Glu-486 also accepts a hydrogen bond from the Discussion
side chain of Asn-747, and Lys-493 donates a hydrogen
to the backbone carbonyl of Phe-491. Asn-754, which The structure-based design of a novel GluR2 S1S2 con-
struct has redefined the S1 and S2 boundaries requiredis at a site that mediates cyclothiazide sensitivity in
AMPA receptors (Partin et al., 1996), is partially buried to retain ligand binding activity and has facilitated the
crystallization of the ligand binding core in the apo statein the dimer interface and forms an intermolecular hydro-
gen bond with the backbone carbonyl of Ser-729 on the and in the presence of DNQX, kainate, glutamate, and
AMPA. These five structures provide the first views of2-fold related protomer.
the ligand binding core of a ligand-gated ion channel in
conformations that may be associated with functionalHistidine Side Chains Chelate Zinc in the
Glutamate and AMPA Structures states of the channel, thus lending insight into receptor
activation, antagonism, and the molecular basis for li-The glutamate and AMPA complexes were crystallized
in the presence of zinc acetate. Evidence from anoma- gand specificity.
lous difference Fourier maps, which revealed the pres-
ence of five strong peaks of electron density (9–20 s), The Closed Channel State Contains an Expanded
Binding Clefttogether with the chemical environment of these density
peaks, suggested that they were zinc ions. Four of the In the absence of ligand (apo) or in the presence of an
antagonist, the gate of the transmembrane ion channelfive zinc ions are located at interprotomer lattice con-
tacts, while the fifth zinc is chelated by intraprotomer is closed. This resting state of the receptor, we suggest,
possesses a ligand binding core in which domains 1interactions between Glu-431 and His-435 of protomer
C (Figure 6B). All six histidines in the asymmetric unit and 2 are separated and the receptor cleft is open, as
seen in the apo and DNQX-complex structures reported(two per protomer) contact a zinc ion. His-412 in loop
1 of protomers C and B* (asterisk indicates a symmetry- here. In the apo state, the open-cleft conformation is
stabilized by intradomain interactions, while the agonistrelated molecule) in conjunction with Glu-419 (B*) coor-
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Figure 6. Crystal Packing Produces a S1S2J
Dimer with 2-Fold Symmetry
(A) Side views of the noncrystallographic di-
mer formed by protomers A (pink) and C
(green) in the glutamate structure. In these
orientations, the 2-fold rotation axis runs ver-
tically in the plane of the page. Residues mak-
ing interprotomer contacts are colored gray.
Note the proximity of Arg-485, which inter-
acts with glutamate, to interface residues.
(B) Top view of the dimer looking down the
2-fold symmetry axis. Protomer C is on the
left with domain 1 colored green, domain 2
colored cyan, and helices D, J, and K colored
blue. Domain 1 in protomer A is shaded red,
domain 2 is pink, and helices D, J, and K
are in orange. Zinc ions are depicted by pink
spheres. The residues that chelate the zinc
ions in the dimer are gray. Symmetry-related
residues (indicated by asterisk) that partici-
pate in zinc chelation are purple.
(C) Stereo diagram of the interactions be-
tween the protomers. The orientation is the
same as in the left panel of (A). Similar interac-
tions also occur in the dimer found in the
S1S2J-apo, DNQX, kainate, and AMPA struc-
tures.
bound state(s) is stabilized by agonist-receptor and in- zole ring binding site as well. By occupying the ligand
binding cleft near the axis of rotation that describes theterdomain interactions. Glu-705, which is the counterion
of the agonist a-amino group, is bound to Lys-730 and relative movement of domains 1 and 2 in the apo to
AMPA transition, DNQX stabilizes the open-cleft confor-Thr-655, thus occupying the anion binding site at the
base of helix F and disfavoring domain closure in the mation via antagonist–receptor interactions. The 7-nitro
group of DNQX “braces” the clamshell-like S1S2 coreabsence of ligand binding. Although related bacterial
periplasmic ligand binding proteins, such as glucose/ in an open conformation by binding to Thr-686, thus
completely blocking the interaction that Thr-686 on do-galactose binding protein and the histidine binding pro-
tein adopt closed-cleft conformations in the apo state main 2 would make with Glu-402 on domain 1 in an
agonist-bound state (Armstrong et al., 1998). The larger(Flocco and Mowbray, 1994; Wolf et al., 1994), we sus-
pect that the ligand binding cores of iGluRs do not be- quinoxalinedione antagonist 2,3-dihydroxy-6-nitro-7-
sulphamoylbenzoquinoxaline (NBQX) probably bindshave in a similar manner due to intradomain interactions
as described above and to intersubunit interactions in more tightly because the 7-sulphamoylbenzo entity can
interact with residues near Thr-686 in domain 2 (Honore´the intact receptor.
Competitive quinoxalinedione antagonists like DNQX et al., 1988).
By contrast to the quinoxalinedione compounds, we“work” by occupying the sites to which the a-carboxyl
and a-amino groups of agonists bind and, in comparison suggest that amino acid–derived antagonists “brace”
domains 1 and 2 in an open-cleft conformation by ex-with AMPA, by overlapping with nearly all of the isoxa-
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tending the length of the linker between the a-carbon In contrast to a previous model for receptor activation
(Mano et al., 1996), we propose that the activated statesubstituents and the anionic “R” moiety, relative to ago-
nists. For example, 2-amino-3-[5-tert-butyl-3-(phospho- involves the interaction of agonists with both lobes of
S1S2 and that the activated conformation is similar tonomethoxy)-4-isoxazolyl]-propionic acid (ATPO) con-
tains a z-phosphate (Moller et al., 1999) that probably our agonist-bound structures. If agonist binding to do-
main 1 were sufficient to activate the receptor, one mightinteracts with the base of helix F, much like the sulfate
anion in the GluR2 S1S2-DNQX complex. ATPO was predict that kainate would activate AMPA receptors as
fully as glutamate, since the contacts that kainate makesreadily modeled into the DNQX binding site by using the
positions of the a-carbon substituents of AMPA in the with domain 1 are very similar to those that glutamate
makes. However, the interactions between kainate andAMPA cocrystals and the sulfate ion in the DNQX com-
plex as guides. Indeed, there are a number of NMDA domain 2 are what primarily distinguish kainate from
glutamate and AMPA. Specifically, Leu-650 in domainreceptor antagonists that have the equivalent of 3–5
methylene groups between the a-carbon and the anionic 2 is in van der Waals contact with the isopropenyl group
of kainate, thus preventing domain 2 from moving to a“R” substituent (Wheal and Thomson, 1995), in compari-
son to the 2 methylene groups between the a-carbon glutamate-like position (Figure 3B).
Activation of AMPA receptors is coupled to rapid de-and the g-carboxyl group in glutamate.
Even though DNQX stabilizes the GluR2 ligand binding sensitization, and receptor desensitization is accompa-
nied by a z5- to 10-fold increase in AMPA or glutamatecore in an open conformation, relative to the apo state
DNQX does induce a modest extent of domain closure affinity as determined by the effects of allosteric modula-
tors on ligand binding (Kessler et al., 1996) and by analy-and promotes the local conformational rearrangement
of Glu-705 to its agonist-state conformation. In the case sis of nondesensitizing mutants (Stern-Bach et al.,
1998). Indeed, the agonist affinities measured for theof the wild-type receptor, these conformational changes
do not result in channel activation. However, introduc- S1S2J construct studied here are most similar to the
high-affinity binding state reported for presumably de-tion of the so-called Lurcher mutation (Zuo et al., 1997)
into GluR1 results in a receptor that is activated by sensitized recombinant AMPA receptors. Thus, the con-
formations of the ligand binding core in the agonist-CNQX, a compound closely related to DNQX and an
antagonist of wild-type AMPA receptors (Taverna et al., bound structures reported here may also be similar to
the receptor’s conformation in the equilibrium-desensi-2000). This relatively subtle mutation of a single alanine
to a threonine maps to a region of glutamate receptors tized state. However, based on the magnitude of esti-
mated affinity differences between the nondesensitizedand potassium channels that is near the predicted ion
channel gate and not in the S1S2 constructs described and desensitized states, the energetic difference be-
tween the activated and desensitized states is small andhere (Doyle et al., 1998; Chen et al., 1999; Perozo et al.,
1999). We suggest that the Lurcher mutation results in on the order of 1–2 hydrogen bonds. Alternatively, small
differences (18–38) in domain closure could also resulta GluR1 receptor that is activated by a much smaller
extent of domain closure, relative to the wild-type recep- in an overall modulation of agonist affinity. Because
tor. Different antagonists which have widely variable most of the residues that have been implicated in desen-
structures may yield varying degrees of domain closure sitization map to the S1S2 surface, it is likely that differ-
and may thus elicit a range of agonist or antagonist ences between the activated and desensitized states
activities at iGluRs containing Lurcher or Lurcher-like primarily involve intersubunit contacts that in turn result
mutations (Kohda et al., 2000). in small, but still significant, conformational changes
in the ligand binding core. The difference in extent of
desensitization observed for glutamate versus kainateChannel Activation and Desensitization
On the basis of the structures reported here, we propose (Patneau et al., 1993) is likely the result of differences
in domain closure that in turn lead to differences inthat substantial closure of the ligand binding cleft leads
to activation (opening) of the ionic channel gate. Full intersubunit contacts. Of course, studies that probe the
structure of the intact receptor will ultimately be requiredagonists, such as glutamate and AMPA, maximally acti-
vate AMPA receptors, measured either in terms of peak to provide a definitive answer to the questions of domain
closure and channel activation and desensitization.current or in terms of steady-state currents in the pres-
ence of the desensitization blocker cyclothiazide, and Kainate receptors, which are fully activated by kai-
nate, have a valine instead of a leucine at the positionthey induce the same maximal extent of domain closure
(see Figure 4). Kainate, in contrast to glutamate and equivalent to 650 in GluR2. When the corresponding
leucine is changed to a valine or a threonine in GluR1,AMPA, is a partial agonist at AMPA receptors, as deter-
mined from macroscopic (Patneau et al., 1993; Stern- the resulting mutants have EC50 values for kainate that
are lower by 6- and 20-fold, respectively (Mano et al.,Bach et al., 1998; Koike et al., 2000) and single-channel
recordings (Swanson et al., 1997b). On the basis of the 1996). The Leu to Thr mutant exhibited a z2-fold greater
potentiation by cyclothiazide in comparison to the wild-crystal structures of the two GluR2 S1S2 complexes with
kainate, the 128 of domain closure seen in the kainate type receptor, suggesting that the mutation increased
the extent of desensitization. Thus, in terms of desensiti-structures is substantially less (88; see Figure 4C) than
that produced by glutamate and AMPA (208), suggesting zation, kainate acting on the mutant receptor has be-
come more similar to the action of glutamate on wild-a positive correlation between domain closure and re-
ceptor activation. Perhaps the intermediate domain clo- type receptors. Unfortunately, it is not clear how the
mutation affects activation because the studies weresure elicited by kainate is translated into an intermediate
conformation of the receptor at the transmembrane not carried out with sufficient time resolution so as to
accurately measure the peak currents. Modeling studiesgate.
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(data not shown) show that replacing Leu-650 by valine 1999). When the Asp-651 and Ser-652 peptide bond flips
from its conformation in the apo, DNQX, and kainateor threonine allows the ligand binding core to adopt a
glutamate-like conformation in the presence of bound complexes to its conformation in the AMPA and gluta-
mate complexes, two additional hydrogen bonds arekainate. The significantly lower EC50 for the threonine
mutant is perhaps due to a hydrogen bond between formed between domains 1 and 2. These interactions
knit the “roof” of the ligand binding site closed and maythe threonine hydroxyl and the g-carboxyl of kainate.
Therefore, we suggest that differences in the ligand further stabilize the closed-cleft conformation. Interest-
ingly, the AMPA and glutamate crystal forms, which arebinding pocket enable kainate to induce a similar degree
of domain closure at kainate receptors as AMPA and isomorphous and have similar lattice contacts, are not
identical in terms of the conformation at the Asp-651glutamate induce at AMPA receptors, reinforcing the
notion that activation is a conserved process across the and Ser-652 peptide bond. AMPA may more effectively
stabilize the flipped conformation because it binds moreiGluR family (Stern-Bach et al., 1998).
The substantial difference in conformation we see be- tightly and promotes slightly greater domain closure.
The precise role, if any, that the conformational vari-tween the apo and agonist-bound structures stands in
contrast to results obtained from small-angle x-ray scat- ability at the Asp-651 and Ser-652 peptide bond plays
in the activation, desensitization, or deactivation of thetering (SAXS) experiments on a longer GluR4 S1S2 con-
struct that found no change in the radius of gyration in receptor is unclear. However, elements that stabilize the
conformation of the agonist-bound receptor are likelythe presence and absence of agonist (Abele et al., 1999).
Similar studies performed on the leucine/isoleucine/ to slow the rate of agonist release and deactivation. In
the GluR2 S1S2 structure, adjacent to the Asp-651 andvaline binding protein found a 1.0 A˚ decrease in Rg upon
ligand binding (Olah et al., 1993) and for the related Ser-652 peptide bond is a site in kainate receptors (Asn-
721 in GluR6) that is homologous to Thr-686 in GluR2glutamine binding protein the calculated DRg between
the apo and liganded state is 1.3 A˚ (Hsiao et al., 1996; and mediates differences in domoate deactivation rates
between GluR5 and GluR6 (Swanson et al., 1997a). BySun et al., 1998). The reason for the discrepancy be-
tween the crystallography and SAXS experiments is un- analogy to the kainate receptors, the interdomain hydro-
gen bonds that residues Asp-651 and Ser-652 make toclear but may be due to differences in the S1S2 con-
structs or to heterogeneity in the conformation of the domain 1 may also modulate receptor deactivation and
agonist release. Although z1808 rotations of trans pep-apo state. Stabilizing the open-cleft conformation by
the addition of an antagonist may help to clarify results tide bonds are not common, there are a number of
previously documented occurrences in which peptidefrom SAXS experiments.
bonds flip depending on the functional state of the pro-
tein (Nar et al., 1991; Romero et al., 1996; Emsley et al.,The GluR2 Ligand Binding Core Has
2000). In the case of iGluRs, our finding of the peptideZinc Binding Sites
bond flip at Asp-651–Ser-652 is novel, and it may provideVesicular zinc is particularly abundant in the hippocam-
yet another mechanism by which the activities of iGluRspus and cerebral cortex and is released, along with
are modulated.glutamate, during electrical stimulation (Perez-Clausell
and Danscher, 1985). At selected hippocampal syn-
apses, concentrations as high as 300 mM have been The GluR2 Ligand Binding Core Forms
measured (Assaf and Chung, 1984). Micromolar concen- a “Dimer” in the Crystal
trations of zinc potentiate currents from both native The presence of a similar “dimer” in all six of the S1S2J
(Mayer and Vyklicky, 1989) and recombinant AMPA re- crystal forms reported here is striking. Although the iso-
ceptors (Dreixler and Leonard, 1994). Dreixler et al. lated ligand binding core is predominately monomeric
(1994) found that in the presence of calcium, zinc en- in solution, as judged by size-exclusion chromatography
hanced kainate-induced currents on GluR3 but not and analytical ultracentrifugation (unpublished data),
GluR1 receptors (Dreixler and Leonard, 1994). In the data from other groups on related receptors suggests
AMPA and glutamate cocrystal structures described that the extracellular domains of iGluRs may assemble
here, we find a number of zinc binding sites formed in dimeric units. For example, Kuusinen et al. found that
in part by histidine residues. Interestingly, His-412 is the entire extracellular domain of GluR4 behaves as a
conserved in GluR2-4, whereas GluR1 contains an ala- dimer on a size-exclusion column and in sucrose density
nine at this position; His-435 is conserved throughout gradients (Kuusinen et al., 1999). A NMDA receptor li-
the AMPA receptor subunits. Although the mecha- gand binding core appears to adopt several oligomeriza-
nism(s) underlying the effects of zinc on AMPA receptors tion states, one of which is dimeric (Ivanovic et al., 1998).
are unknown, our crystallographic data suggest that The ligand binding domain from the metabotropic gluta-
the histidine residues in S1S2 are candidates for zinc mate receptors, which is homologous to the iGluR ATD,
binding sites in the intact receptor that may, for example, forms disulfide-linked dimers (Romano et al., 1996; Oka-
bridge neighboring subunits and modulate receptor ac- moto et al., 1998). Thus, the molecular symmetry of
tivity. the extracellular portions of iGluRs may differ from the
symmetry of the ion channel, the latter of which is proba-
bly 4-fold symmetric.The Flipped Peptide Bond May Stabilize
a Closed Binding Cleft Determination of biologically relevant protein inter-
faces by analysis of crystal packing interactions isNumerous hydrogen bonding interactions between do-
main 1 and domain 2 are important for conferring affinity fraught with uncertainty, and the “dimer” we observe in
our crystals may not be related to interfaces in the intactand specificity to agonist binding (Dingledine et al.,
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Figure 7. Mechanism of Glutamate Binding
Shown are the ligand binding sites in the apo (A), DNQX complex (B), and glutamate complex (C) states. Residues on a 2-fold related subunit
are indicated by asterisks, and a solvent-filled cavity that might represent the binding site for cyclothiazide is depicted by a light blue ellipse
and is located at the dimer interface. In (B) DNQX has been removed and glutamate has been modeled in its place in an effort to model a
complex between the receptor and glutamate prior to domain closure.
receptor. By the standard criteria of buried surface area form (Partin et al., 1996). In our structures, the amide
side chain of Asn-754 makes an intersubunit hydrogenand the number of polar and nonpolar interactions
(Conte et al., 1999), the S1S2J dimer interface is large bond to the backbone carbonyl of Ser-729, a residue
that is located near the interdomain hinge. Located onwith relatively few hydrogen bonds, an observation that
may explain why dimers do not predominate in solution. “top” of the dimer is a large depression that is near the
arginine/glycine (R/G) RNA editing site that modulatesOnly further experiments will validate or refute the rela-
tionship between the S1S2J “dimer” observed in the the rate of receptor desensitization (Lomeli et al., 1994).
The S1S2 constructs reported here have a glycine atcrystals and the S1S2 interface(s) in the intact receptor.
Nevertheless, it has not escaped our attention that a this position; modeling arginines into the Gly-743 sites
partially fills this hole and generates a positive electro-number of residues implicated in receptor desensitiza-
tion are clustered in the dimer interface. Leu-483 is lo- static potential at the surface without creating any seri-
ous steric clashes. The dimer interface observed in ourcated at a position that modulates receptor desensitiza-
tion in GluR3; when the equivalent leucine in GluR3 is crystals illustrates how sites implicated in receptor de-
sensitization are juxtaposed across from the ligandchanged to tyrosine, the resulting mutant does not de-
sensitize (Stern-Bach et al., 1998). In fact, introduction binding cleft of an adjacent subunit; perhaps one mech-
anism underlying receptor desensitization involves theof any aromatic amino acid dramatically slows desensiti-
zation (Stern-Bach et al., 1998). Recent experiments modulation of interactions between helices J and K of
one subunit and the ligand binding cleft of anotherhave shown that mutation of Leu-483 in GluR2 to Tyr
also produces a nondesensitizing receptor (M. Mayer, subunit.
personal communication). In the dimer interface, the
side chain of Leu-483 is in van der Waals contact with A Subsite Map of the Agonist Binding Cleft
On the basis of conserved locations of the agonist hy-Lys-752. If we assume that the dimer interface we see
in the crystal is relevant to the intact receptor, then the drogen bond donors and acceptors as well as hydropho-
bic groups, we have defined seven positions (Figure 3D)introduction of aromatic residues at position 483 might
result in favorable cation–p interactions with Lys-752 within the binding cleft that are common interaction sites
for AMPA receptor agonists. We predict that the a-car-on the 2-fold related subunit. A stabilizing interaction
between residues at positions 483 and 752 may in turn boxyl and a-amino groups of all AMPA receptor agonists
will occupy sites A and B, respectively. The region ofslow desensitization.
Other sites in the dimer interface that also modulate the agonist linking the zwitterion to the g-anionic moiety
is positioned in site C and will form hydrophobic interac-receptor desensitization are Asn-754 and Gly-743. Asn-
754 is a site that mediates allosteric regulation of desen- tions with Tyr-450. Sites D and E are occupied by the
g-carboxyl oxygens from glutamate and kainate. Thesesitization in AMPA receptors by cyclothiazide (Partin et
al., 1995); a simple Asn to Ser change is sufficient to sites connect the agonist to Ser-654 and Thr-655 in
domain 2. The sixth site (F) is occupied by a moietyconfer sensitivity to cyclothiazide in the GluR1-flop iso-
Crystal Structures of GluR2 Ligand Binding Core
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Figure 8. A Model for Glutamate Receptor Activation and Antagonism
The tetramer model was constructed by placing two dimers side by side (orientation as in the right side of Figure 6A), so that the interdimer
2-fold is in the center of the 4 subunits and coincides with the channel 4-fold. The dimensions of this dimer-of-dimers arrangement is z80
A˚ 3 55 A˚ 3 50 A˚ (l 3 w 3 h). Each dimer is composed of a pink and a purple S1S2 core. Domain 1 and domain 2 are labeled as D1 and D2,
respectively. The channel region depicted here encompasses M1–3 and the P region. The ATD has not been modeled.
(water in the glutamate and kainate complexes, isoxa- Lys-730 may act as a switch between the apo and full
agonist–bound states; in the apo state it interacts withzole nitrogen in the AMPA structure) that will link the
agonist to the backbone amide of Glu-705. Site G is the Glu-705 and in the full agonist state Lys-730 is near Asp-
728. Indeed, Asp-728 is located at a hinge region in ahydrophobic pocket in domain 1. From our structures,
only the 5-methyl substituent from AMPA occupies this transdomain b strand, and the Lys-730 and Asp-728
interaction may stabilize the hinge in the full agonist–site. However, if a few side chains undergo modest re-
arrangements, the pocket could accommodate the bound state.
To connect the conformational changes that we havet-butyl group from ATPA (Matzen et al., 1997). Thus,
agonist atoms in sites A and B form polar interactions documented in the ligand binding core to opening of
the ion channel gate, we have developed a model of anwith domain 1, while subsites D, E, and F form hydrogen
bonds with domain 2. We anticipate that subsites A–F assembled receptor, shown in Figure 8. This model is
based on the following assumptions: (1) AMPA recep-will always be occupied with either agonist atoms or
water molecules, while only some agonists will fill site tors are tetrameric; (2) the transmembrane domain has
z4-fold rotational symmetry; (3) the ligand binding coresG. Only the isopropenyl group from kainate does not
occupy any of these subsites; perhaps agonists with are dimeric; and (4) the gate is located proximal to the
extracellular surface of the membrane. In our model,substituents outside this subsite map will be partial
AMPA receptor agonists. agonist binding induces a clockwise screw-axis move-
ment of domain 2 up and away from the channel 4-fold
symmetry axis, causing a rotation of the protein nearMechanism of Ligand Binding and Coupling
to Channel Gating the putative gate. This movement is based on superpo-
sitions of the apo and glutamate-bound dimers thatThe series of structures presented here allow us to de-
velop a mechanism for glutamate binding to the ligand show that the two “linker” regions separate by z5 A˚,
measured perpendicular to the 2-fold axis, and undergobinding core, as illustrated in Figure 7. In the apo state,
the ligand binding cleft is open, domains 1 and 2 are a rotation of z58 around the 2-fold axis and a translation
of z4 A˚ along the 2-fold axis. According to our model,separated, and Glu-705 is bound to the base of helix F
and to Lys-730. Using the DNQX structure as a model the binding of a partial agonist results in correspondingly
smaller conformational changes. Antagonists stabilizefor the initial receptor-glutamate complex, we suggest
that glutamate binds to domain 1 via interactions be- the ligand binding core in an open-cleft conformation
and thus preclude rotation and separation of the ligandtween its a-amino and a-carboxyl groups and Arg-485,
Thr-480, Pro-478, and Glu-705, in agreement with previ- binding regions and subsequent opening of the ion
channel gate.ous studies of bacterial periplasmic ligand binding pro-
teins (see for example, Sack et al., 1989) and with recent
time-resolved ligand binding studies of GluRD S1S2 Conclusion
This series of structures marks a novel high-resolution(Abele et al., 2000). The initial binding of glutamate to
domain 1 occurs because this binding site is largely study for a portion of a ligand-gated ion channel in the
apo, antagonist-, and agonist-bound states. Compari-preorganized, even in the apo state. Following this initial
contact, shown in Figure 7B, domain closure occurs, sons of these five structures have uncovered plausible
mechanisms underlying the antagonism, activation, andand the g-carboxyl group interacts with the base of helix
F and water molecules 1–3 (Figure 7C); we suggest that modulation of iGluRs. Based on the spectrum of confor-
mations presented here, we propose that the substantialthis step leads to channel activation. In the agonist-
bound structures, Lys-730 is proximal to Asp-728. Thus, degree of domain closure that occurs upon agonist bind-
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13%–18% PEG 8000, 0.1–0.25 M Zn(OAc)2, and 0.1 M cacodylateing initiates iGluR channel activation. Furthermore, com-
at pH 6.5. The kainate crystallization buffer consisted of 8%–15%parison of the full agonist– and partial agonist–bound
PEG1450 and 0.1 M NaOAc at pH 5.0. Crystals were soaked instructures indicates that the channel activation level is
crystallization buffer supplemented with the corresponding ligand
dependent upon the conformation of the ligand binding and 10%–12% glycerol prior to flash freezing in liquid nitrogen.
domain and, more specifically, the extent of S1S2 do-
main closure. In contrast to the large conformational
Structure Determinationchange induced by agonists, the binding of competitive
The glutamate- and kainate-S1S2J structures were determined by
antagonists, such as DNQX, produces minimal domain MR using the S1S2I-kainate structure as the search probe. Taking
closure and therefore these ligands do not activate the advantage of its isomorphism with the glutamate crystal form, the
AMPA structure was refined by difference Fourier techniques. Forwild-type receptor. The dimer observed in these crystal
all three structures, the refinement protocol began with rigid bodyforms supports a role for intermolecular interactions in
refinement followed by a slow-cool simulated-annealing run at 4000receptor desensitization and suggests that the iGluR
K to reduce model bias. Iterative rounds of model building (includingtetramer may consist of dimers-of-dimers. Zn21 binding
side chains, waters, ligands, and ions) into omit maps and positional
sites and peptide-bond flipping may also be involved in and individual B-value refinement were performed until the Rfree con-
modulation of receptor activity by altering inter- and verged. NCS restraints (300 kcal/mol* A˚2) were applied to the three
molecules in the glutamate asymmetric unit (a.u.) in the initial roundsintrasubunit interactions, respectively. The mechanisms
of refinement. However, restraints were completely released whenwe have put forth to explain the behavior of the AMPA
the Rfree reached 0.34. Ligands were modeled into Fo-Fc maps usingGluR2 receptor may also be germane to the understand-
either the small-molecule crystal structure (Honore´ and Lauridsen,ing of kainate and NMDA receptors.
1980; Todeschi et al., 1997) or a rotamer from the O library when
the Rfree dropped below 0.30. Refinement of the kainate structure
Experimental Procedures was stopped when superpositions of the S1S2I- and S1S2J-kainate
models revealed no significant differences in the mode of kainate
Construct Design binding and the orientation of the lobes. The rmsd calculated for all
The three amino acid changes made to the N terminus of S1S2I, Ca atoms between the two kainate structures was 0.61 A˚. Because
G389R, L390G, and E391A were introduced by way of cassette the S1S2I data extended to 1.6 A˚ and was collected on a crystal
mutagenesis using the following oligos: PRM1: 59-CAT GGG CTC grown closer to physiological pH (6.5), we used this structure for
AGG AAA TGA CAC TAG TCG CGG TGC AAA CAA AAC TGT GGT the majority of the crystallographic analysis.
G-39 and PRM2: 59-GTG ACC ACC ACA GTT TTG TTT GCA CCG The DNQX crystals grew in two different lattices that differed by
CGA CTA GTG TCA TTT CCT GAG CC-39, where underlined letters a doubling of the c axis in the larger form. The DNQX structure was
indicate mutated bases. The PRM1:PRM2 cassette was cloned into determined by a combination of MR and MAD using the larger form
pS1S2I to generate pS1S2I2 using the NcoI and BstEII restriction prior to discovery of the smaller lattice. A MR solution could only
sites. The sequence at the linker was changed to MIKK506-GT-P632IES be obtained when the kainate dimer, which was generated by super-
by strand-overlap extension PCR using the following primers: PRM3: imposing a S1S2I-kainate complex on each molecule in the gluta-
59-GAA GGG TAC CCC CAT CGA AAG TGC TGA G-39, PRM4: 59-TCG mate “dimer,” was used a search probe. Even though the MR solu-
ATG GGG GTA CCC TTC TTG ATC ATG ATA G-39, PRM5: 59-GGG tion had a correlation coefficient of 60.1, extensive refinement only
CTA CTG TGT TGA CTT-39, and PRM6: 59-CTT CTG CGG TAG TCC lowered the Rfree to 40.0%. Maps inspected at this point contained
TC-39. PRM4 and PRM5 were combined with pS1S2I in one PCR reasonable density for all of domain 1, but the density for most of
reaction to generate the S1 half of the insert, while PRM3 and PRM6 domain 2 was uninterpretable. Therefore, a 3-wavelength MAD data
were used to synthesize the S2 half. In a third PCR reaction, the S1 set was collected on a selenomethionine-derivatized DNQX crystal.
and S2 PCR products were combined with PRM5 and PRM6 to Anomalous difference Fourier maps calculated using structure fac-
create the linker insert. The insert was digested with PstI and BglII, tors obtained from data measured at the selenium K peak and
cloned into pS1S2I2 that had been digested with the same enzymes, phases from the DNQX molecular replacement structure clearly indi-
and sequenced. cated the location of all 40 selenium sites. SOLVE (Terwilliger and
Berendzen, 1999) was used to refine the position and occupancy
Activity Assay of the sites and to calculate 4.0 A˚ MAD phases (figure of merit,
Protein production, refolding, and purification were carried out as FOM, of 0.71). After density modification in DM including solvent
previously described (Chen et al., 1998). The 3H-AMPA Kd value and flattening, histogram matching, phase extension to 2.5 A˚, and 4-fold
DNQX IC50 were measured for S1S2J at pH 7.0 and pH 5.0 following NCS averaging, the FOM was 0.81. The electron density in these
previously published protocols (Chen and Gouaux, 1997). The buffer maps was excellent, allowing for an unambiguous repositioning of
used for the low pH measurements contained 30 mM NaOAc, pH domain 2. Eventually, a 1.8 A˚ native data set was collected on
5.0, instead of 30 mM Tris, pH 7.0. IC50 values were also determined the smaller DNQX crystal form, which was solved by molecular
for glutamate and kainate at pH 7.0 by competition binding experi- replacement (CC 5 69.2). A DNQX model constructed from the pub-
ments. For competition experiments, 20 nM 3H-AMPA (10.6 Ci/mmol) lished x-ray coordinates (Kubicki et al., 1996) was placed into 1.8 A˚
was used in all samples and either 1 nM–0.1 mM DNQX, 10 pM–500 Fo-Fc density when the Rfree reached 28.6%. The refined DNQX “di-
mM L-glutamate, or 1 nM–1 mM kainate. Ligand binding experiments mer” structure was used as the search probe for the apo structure
were carried out in duplicate. determination (CC 5 64.6). IC50 measurements at the pH value of
the crystallization buffer confirmed that the DNQX affinity is not
compromised at pH 5.0.Crystallization
S1S2J was dialyzed extensively against 10 mM HEPES, pH 7.0, 20 Apo, kainate, and glutamate data sets were collected using cop-
per Ka radiation and an R-Axis IV area detector. The x-ray beammM NaCl, and 1 mM EDTA to remove all traces of glutamate (except
for material intended for cocrystallization with glutamate). Final li- was focused using a compound reflector geometry to symmetrically
image the 300 mm beam (J. Lidestri and W. A. Hendrickson, personalgand concentrations were: 3 mM DNQX, 10 mM kainate, 2 mM
(S)-AMPA, and 10 mM L-glutamate. All crystals were grown at 48C communication). The AMPA data and the DNQX MAD and native
data were collected on a Quantum 4 CCD detector at the NSLSin hanging drops containing a 1:1 (v/v) ratio of protein solution (7
and 14 mg/ml as determined by OD280) to reservoir solution. DNQX beamline X4A. Data for all crystal forms was indexed, scaled, and
merged using HKL (Otwinowsky and Minor, 1997). All molecularcrystallization buffer contained 17%–22% PEG 4000, 0.25–0.4 M
ammonium sulfate, and 0.1 M NaOAc at pH 5.0. The apo crystals replacement calculations were performed in AMoRe (Navaza, 1994).
Refinements were carried out in X-PLOR (Bru¨nger, 1992). O (Jonesgrew in a condition identical to that for DNQX except that 19%–24%
PEG 8000 replaced the PEG 4000 and 10% (v/v) glycerol was in- and Kjeldgaard, 1997) was used for model building and for dis-
playing maps. Superpositions and various structural analyses werecluded with the protein. Glutamate and AMPA cocrystals grew in
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calculated using LSQMAN (Kleywegt and Jones, 1994) and X-PLOR (1999). Kainate receptors: subunits, synaptic localization and func-
tion. Trends Pharmacol. Sci. 20, 26–35.(Bru¨nger, 1992). The extent of domain “closure” was determined
using the script HINGEFIND (Wriggers and Schulten, 1997) imple- Conte, L.L., Chothia, C., and Janin, J. (1999). The atomic structure
mented in X-PLOR (Bru¨nger, 1992). Using the ApoA structure as a of protein-protein recognition sites. J. Mol. Biol. 285, 2177–2198.
reference state, the rotation required to fit the second domain follow-
Dingledine, R., Borges, K., Bowie, D., and Traynelis, S.F. (1999). The
ing superposition of the first is defined as the extent of “domain
glutamate receptor ion channels. Pharmacol. Rev. 51, 7–61.
closure.” All other crystallographic calculations were carried out in
Doyle, D.A., Morais Cabral, J., Pfuetzner, R.A., Kuo, A., Gulbis, J.M.,the CCP4 program suite (CCP4 Project, 1994).
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